SURMOUNT-1 demonstrated 15%, 19.5%, and 20.9% body weight reduction at 5, 10, and 15 mg respectively over 72 weeks FDA approvals : Mounjaro (T2D, May 2022) and Zepbound (obesity, November 2023) Cardiovascular outcomes : SURPASS-CVOT in progress to evaluate cardiovascular safety and efficacy Global availability : Approved in US, EU, and numerous international markets Side Effects and Safety Comparison# Mazdutide Side Effects# GI effects : Nausea, diarrhea, and vomiting consistent with GLP-1 class
We encourage you to be open and honest with us
Who May Consider Reviewing AgelessRx With a Healthcare Professional AgelessRx May Fit Prospective Patients Who: Have been following longevity science and want structured clinician access: Prospective patients who have read extensively about these compounds and want access to a clinician willing to discuss them may find AgelessRx provides a more centralized option than piecing together separate services
The MHRA's Yellow Card scheme (yellowcard.mhra.gov.uk) allows patients and healthcare professionals to report suspected side effects, helping to build a comprehensive safety profile for these medications
